Mgr. Miroslav Boudný, Ph.D.
Junior researcher, Marek Mráz Research Group
Office: bldg. E35/281
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 7500 |
---|---|
E‑mail: |
Total number of publications: 25
2021
-
Duplikace 8q24 v chronické lymfocytární leukémii: Cytogentická a molekulárně-biologická analýza aberací genu MYC.
Year: 2021, type: Conference abstract
-
miR-29 influences CD40 signaling in chronic lymphocytic leukemia (CLL): and axis affected by BCR inhibitors.
Year: 2021, type: Conference abstract
-
Patient-derived Xenograft Model of Chronic Lymphocytic Leukaemia Based on Mimicking Its Microenvironment.
Year: 2021, type: Conference abstract
-
The biology of miRNAs in B cell malignancies and their use as biomarkers.
Year: 2021, type: Conference abstract
-
The role of long non-coding RNAs in the BCR-mediated activation of malignant B cells.
Year: 2021, type: Conference abstract
2020
-
ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias
CANCER TREATMENT REVIEWS, year: 2020, volume: 88, edition: AUG, DOI
-
The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology
Klinická onkologie, year: 2020, volume: 33, edition: 1, DOI
2019
-
ATR-CHK1 signaling is active and targetable in quiescent CLL cells
Year: 2019, type: Conference abstract
-
Cytogenetická a molekulárně biologická analýza genu a proteinu Myc u pacientů s chronickou lymfocytární leukémií.
Year: 2019, type: Conference abstract
-
Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells
Haematologica, year: 2019, volume: 104, edition: 12, DOI